Martin Edelman, MD, Talks About Improving Outcomes in the Management of NSCLC
Martin Edelman, MD, Greenbaum Cancer Center, Baltimore, MD, says that organizations like NCCN and ASCO have guidelines for the management of non-small cell lung cancer (NSCLC). "I think that by utilizing these various clinical as well as biological markers, we can develop therapies that are tailored to the individual patient and have substantial evidence to support their use," said Dr Edelman.
This video was taken on May 2, 2013, at the NAMCP Spring Managed Care Forum in Orlando, FL.
The pharmaceutical industry mounted a new challenge to a federal plan that would require generic drug companies to take the initiative to update their labels to warn consumers whenever health risks were discovered.
HHS Secretary Sylvia M. Burwell's announcement that CMS would move to value-based payments was a nail in the coffin for those skeptics who believed the push for value contracting would pass, according to Joseph Gifford, MD, chief executive of the Providence-Swedish Health Alliance.
The overhaul would fix the Medicare reimbursement system and align payment with CMS' current efforts to reward value-based care. For the first time, the wealthiest seniors would be asked to pay higher premiums.